Moogene Medi Co., Ltd. (XKON:322970)
South Korea · Delayed Price · Currency is KRW 2,165.00
+40.00 (1.88%)
At close: Mar 5, 2026
Moogene Medi Market Cap
Moogene Medi has a market cap or net worth of 20.15 billion as of March 6, 2026. Its market cap has decreased by -15.40% in one year.
Market Cap
20.15B
Enterprise Value
n/a
Revenue
12.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,165.00
Market Cap Chart
Since June 24, 2020, Moogene Medi's market cap has decreased from 39.69B to 20.15B, a decrease of -49.22%. That is a compound annual growth rate of -11.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.15B | 0.60% |
| Dec 30, 2025 | 20.03B | -14.46% |
| Dec 30, 2024 | 23.42B | 26.91% |
| Dec 28, 2023 | 18.45B | -30.26% |
| Dec 29, 2022 | 26.46B | -11.50% |
| Dec 30, 2021 | 29.90B | -25.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Sciences | 54.87B |
| NGeneBio | 52.23B |
| J2KBIO | 46.25B |
| SCM Lifescience | 38.46B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.40B |
| ADBiotech | 28.18B |